590 related articles for article (PubMed ID: 15878737)
1. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
2. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
3. Familial polycythemia due to truncations of the erythropoietin receptor.
Forget BG; Degan BA; Arcasoy MO
Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
5. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
Kralovics R; Sokol L; Prchal JT
J Clin Invest; 1998 Jul; 102(1):124-9. PubMed ID: 9649565
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.
Watowich SS; Xie X; Klingmuller U; Kere J; Lindlof M; Berglund S; de la Chapelle A
Blood; 1999 Oct; 94(7):2530-2. PubMed ID: 10498627
[TBL] [Abstract][Full Text] [Related]
7. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
9. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
[TBL] [Abstract][Full Text] [Related]
10. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
[TBL] [Abstract][Full Text] [Related]
12. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
Sulahian R; Cleaver O; Huang LJ
Blood; 2009 May; 113(21):5287-97. PubMed ID: 19336760
[TBL] [Abstract][Full Text] [Related]
14. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
17. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.
Sokol L; Luhovy M; Guan Y; Prchal JF; Semenza GL; Prchal JT
Blood; 1995 Jul; 86(1):15-22. PubMed ID: 7795221
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
Yoon D; Watowich SS
Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
[TBL] [Abstract][Full Text] [Related]
19. The role of erythropoietin receptor tyrosine phosphorylation in erythropoietin-induced proliferation.
Damen JE; Liu L; Wakao H; Miyajima A; Rosten P; Jefferson AB; Majerus PW; Krosl J; Humphries RK; Krystal G
Leukemia; 1997 Apr; 11 Suppl 3():423-5. PubMed ID: 9209412
[TBL] [Abstract][Full Text] [Related]
20. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras.
Gross M; Ben-Califa N; McMullin MF; Percy MJ; Bento C; Cario H; Minkov M; Neumann D
Br J Haematol; 2014 May; 165(4):519-28. PubMed ID: 24533580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]